Related references
Note: Only part of the references are listed.Multiplexed mRNA Sensing and Combinatorial-Targeted Drug Delivery Using DNA-Gold Nanoparticle Dimers
Maria-Eleni Kyriazi et al.
ACS NANO (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Cancer nanomedicine: a review of recent success in drug delivery
Stephanie Tran et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
The state-of-play and future of antibody therapeutics
Zehra Elgundi et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
Fu Li et al.
CANCER RESEARCH (2016)
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner et al.
NATURE METHODS (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Nanoparticle uptake: The phagocyte problem
Heather Herd Gustafson et al.
NANO TODAY (2015)
Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug Payload
Yilma T. Adem et al.
BIOCONJUGATE CHEMISTRY (2014)
On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles
Ekaterina Y. Lukianova-Hleb et al.
NATURE MEDICINE (2014)
Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: A retrospective study
Mei Liu et al.
ONCOLOGY REPORTS (2014)
Quantifying thiol-gold interactions towards the efficient strength control
Yurui Xue et al.
NATURE COMMUNICATIONS (2014)
Gold Nanoparticles Induce Autophagosome Accumulation through Size-Dependent Nanoparticle Uptake and Lysosome Impairment
Xiaowei Ma et al.
ACS NANO (2011)
Choosing the right cell line for breast cancer research
Deborah L. Holliday et al.
BREAST CANCER RESEARCH (2011)
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
Carol M. Lee et al.
BMC CANCER (2010)
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Steven K. Libutti et al.
CLINICAL CANCER RESEARCH (2010)
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
Alaaldin M. Alkilany et al.
JOURNAL OF NANOPARTICLE RESEARCH (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Tumor Ablation and Nanotechnology
Rachel L. Manthe et al.
MOLECULAR PHARMACEUTICS (2010)
Tuning payload delivery in tumour cylindroids using gold nanoparticles
Byoungjin Kim et al.
NATURE NANOTECHNOLOGY (2010)
The Role of Thiols and Disulfides on Protein Stability
Maulik V. Trivedi et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2009)
Understanding the Role of Surface Charges in Cellular Adsorption versus Internalization by Selectively Removing Gold Nanoparticles on the Cell Surface with a I2/KI Etchant
Eun Chul Cho et al.
NANO LETTERS (2009)
Biodistribution of TNF-α-coated gold nanoparticles in an in vivo model system
Raghav Goel et al.
NANOMEDICINE (2009)
Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance
Greg M. Thurber et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Nanoparticle-mediated cellular response is size-dependent
Wen Jiang et al.
NATURE NANOTECHNOLOGY (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Determination of size and concentration of gold nanoparticles from UV-Vis spectra
Wolfgang Haiss et al.
ANALYTICAL CHEMISTRY (2007)
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis
O Will et al.
LANCET ONCOLOGY (2006)
Amplification of c-erbB2 oncogene - A maior prognostic indicator in uterine serous papillaty carcinoma
AD Santin et al.
CANCER (2005)
High interstitial fluid pressure -: An obstacle in cancer therapy
CH Heldin et al.
NATURE REVIEWS CANCER (2004)
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
KJ Hamblett et al.
CLINICAL CANCER RESEARCH (2004)
Cellular trajectories of peptide-modified gold particle complexes: Comparison of nuclear localization signals and peptide transduction domains
AG Tkachenko et al.
BIOCONJUGATE CHEMISTRY (2004)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
